Hsu Hsien-Yeh, Hua Kuo-Feng, Lin Chun-Cheng, Lin Chun-Hung, Hsu Jason, Wong Chi-Huey
Faculty of Medical Technology, Institute of Biotechnology in Medicine, National Yang-Ming University, 155 Li-Nong Street, Shih-Pai, Taipei, Taiwan.
J Immunol. 2004 Nov 15;173(10):5989-99. doi: 10.4049/jimmunol.173.10.5989.
We have demonstrated that an extract of Ganoderma lucidum (Reishi or Ling-Zhi) polysaccharides (EORP) exerts immunomodulating activities by stimulating the expression of inflammatory cytokines from mouse spleen cells. Interestingly, via responding to LPS in genetic variation of murine macrophage HeNC2 and GG2EE cell lines, and using TLR4 Ab blockage in human blood-derived monocytic macrophages, we have found that the TLR4, but not complement receptor type 3, is a putative receptor of EORP, mediating the consequent immunomodulating events associated with IL-1 gene expression. Based on our studies of reactive oxygen species production, polymyxin B inhibition, and protein tyrosine kinase (PTK) activity, we ruled out the possibility of LPS contamination in EORP. We have found that EORP differentially modulates the protein kinase (PK)-mediated signal transduction pathways associated with inflammatory cytokine IL-1. In human macrophages and murine macrophage J774A.1 cells, EORP was found to up-regulate IL-1 secretion and pro-IL-1 (precursor of IL-1) as well as IL-1-converting enzyme expression. Specifically, EORP rapidly stimulates PTK-mediated phosphorylation, followed by induction of PKs and activation of MAPKs: ERK, JNK, and p38. Using PK inhibitors in the kinase activity assays, Western blot analyses and IL-1 ELISA, we have extensively examined and dissected the role of individual PK in the regulation of pro-IL-1/IL-1. Our findings establish that EORP-mediated signaling pathways are involved in the pro-IL-1/IL-1 regulation: PTK/protein kinase C/MEK1/ERK and PTK/Rac1/p21-activated kinase/p38.
我们已经证明,灵芝多糖提取物(EORP)通过刺激小鼠脾细胞中炎性细胞因子的表达发挥免疫调节活性。有趣的是,通过在小鼠巨噬细胞HeNC2和GG2EE细胞系的基因变异中对LPS作出反应,并在人血源性单核巨噬细胞中使用TLR4抗体阻断,我们发现TLR4而非补体受体3型是EORP的假定受体,介导与IL-1基因表达相关的后续免疫调节事件。基于我们对活性氧产生、多粘菌素B抑制和蛋白酪氨酸激酶(PTK)活性的研究,我们排除了EORP中LPS污染的可能性。我们发现EORP对与炎性细胞因子IL-1相关的蛋白激酶(PK)介导的信号转导途径有不同的调节作用。在人巨噬细胞和小鼠巨噬细胞J774A.1细胞中,发现EORP上调IL-1分泌、前IL-1(IL-1的前体)以及IL-1转化酶的表达。具体而言,EORP迅速刺激PTK介导的磷酸化,随后诱导PKs并激活MAPKs:ERK、JNK和p38。在激酶活性测定、蛋白质印迹分析和IL-1 ELISA中使用PK抑制剂,我们广泛研究并剖析了单个PK在调节前IL-1/IL-1中的作用。我们的研究结果表明,EORP介导的信号通路参与前IL-1/IL-1的调节:PTK/蛋白激酶C/MEK1/ERK和PTK/Rac1/p21激活激酶/p38。